These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25866022)

  • 21. The optimal dose of omega-3 supplementation for non-alcoholic fatty liver disease.
    Li Y; Chen D
    J Hepatol; 2012 Aug; 57(2):468-9; author reply 469-70. PubMed ID: 22433603
    [No Abstract]   [Full Text] [Related]  

  • 22. Dietary omega-3 fatty acid intake and cardiovascular risk.
    Psota TL; Gebauer SK; Kris-Etherton P
    Am J Cardiol; 2006 Aug; 98(4A):3i-18i. PubMed ID: 16919512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The science behind dietary omega-3 fatty acids.
    Surette ME
    CMAJ; 2008 Jan; 178(2):177-80. PubMed ID: 18195292
    [No Abstract]   [Full Text] [Related]  

  • 24. Omega-3 fatty acids offer heart protection in multiple ways. These healthy essential fats provide benefits whether consumed as supplements or from dietary sources.
    Heart Advis; 2011 Aug; 14(8):5. PubMed ID: 23097802
    [No Abstract]   [Full Text] [Related]  

  • 25. [Omega-3 fatty acids, new treatment for depression].
    Tanskanen A; Tiihonen J
    Duodecim; 2004; 120(17):2033-5. PubMed ID: 15559009
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of Omega-3 Fatty Acid Supplements on Arrhythmias.
    Parish S; Mafham M; Offer A; Barton J; Wallendszus K; Stevens W; Buck G; Haynes R; Collins R; Bowman L; Armitage J;
    Circulation; 2020 Jan; 141(4):331-333. PubMed ID: 31986094
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeting the effects of omega-3 and omega-6 fatty acid supplementation on schizophrenic spectrum disorders: role of neuroimaging.
    Sota M; Allegri C; Cortesi M; Barale F; Politi P; Fusar-Poli P
    Med Hypotheses; 2007; 69(2):466-7. PubMed ID: 17324526
    [No Abstract]   [Full Text] [Related]  

  • 28. ω-3 fatty acid supplements for secondary prevention of cardiovascular disease: from "no proof of effectiveness" to "proof of no effectiveness".
    Messori A; Fadda V; Maratea D; Trippoli S
    JAMA Intern Med; 2013 Aug; 173(15):1466-8. PubMed ID: 23779264
    [No Abstract]   [Full Text] [Related]  

  • 29. Fish oil and omega-3 fatty acids.
    Jenkins DJ; Josse AR
    CMAJ; 2008 Jan; 178(2):150. PubMed ID: 18195286
    [No Abstract]   [Full Text] [Related]  

  • 30. Recommend omega-3 fatty acids in pregnancy?
    Schwalfenberg G
    Can Fam Physician; 2007 Aug; 53(8):1299-300; author reply 1300. PubMed ID: 17872843
    [No Abstract]   [Full Text] [Related]  

  • 31. The Unfulfilled Promise of ω-3 Fatty Acid Supplementation.
    Curfman G
    JAMA Intern Med; 2017 Feb; 177(2):194. PubMed ID: 28055040
    [No Abstract]   [Full Text] [Related]  

  • 32. The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive pulmonary disease: a systematic review.
    Atlantis E; Cochrane B
    Int J Evid Based Healthc; 2016 Jun; 14(2):53-63. PubMed ID: 26134547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ω-3 Fatty acids and lutein + zeaxanthin supplementation for the prevention of cardiovascular disease.
    Rizos EC; Ntzani EE
    JAMA Intern Med; 2014 May; 174(5):771-2. PubMed ID: 24638082
    [No Abstract]   [Full Text] [Related]  

  • 34. Responses of dogs to dietary omega-3 fatty acids.
    Bauer JE
    J Am Vet Med Assoc; 2007 Dec; 231(11):1657-61. PubMed ID: 18052798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 fatty acids for secondary prevention.
    Colquhoun D
    J Am Coll Cardiol; 2005 May; 45(9):1552; author reply 1552-3. PubMed ID: 15862440
    [No Abstract]   [Full Text] [Related]  

  • 36. Could omega-3 fatty acids improve quality of life in cancer patients?
    Arshad A; Isherwood J; Dennison A
    Future Oncol; 2015; 11(24):3225-8. PubMed ID: 26562498
    [No Abstract]   [Full Text] [Related]  

  • 37. [Omega-3 fatty acids and acetylcysteine diet supplementation effects on learning performance].
    Iamandei GL; Mocanu V; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):808-12. PubMed ID: 21243807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The power of 3. Omega-3 fatty acids.
    Mayo Clin Health Lett; 2007 Aug; 25(8):6. PubMed ID: 17715541
    [No Abstract]   [Full Text] [Related]  

  • 39. Omega-3 fatty acids and mood disorders.
    Parker G; Gibson NA; Brotchie H; Heruc G; Rees AM; Hadzi-Pavlovic D
    Am J Psychiatry; 2006 Jun; 163(6):969-78. PubMed ID: 16741195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation.
    Arnesen H; Seljeflot I
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):18-27. PubMed ID: 20196966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.